After its introduction in 1987, radiofrequency catheter ablation became est
ablished as a safe and effective therapy for the cure of many cardiac arrhy
thmias in people. The possibility of assessing the relationship between the
anatomical target and the electrophysiologic changes produced by radiofreq
uency pulse delivery has also provided significant improvement in the physi
cian's knowledge of the pathophysiology of the underlying rhythm disturbanc
e. Nowadays, using this therapy, success rates well above 90% with recurren
ce rates lower than 5% are expected after treatment of most regular suprave
ntricular arrhythmias. As catheter ablation techniques develop, success rat
es in the range of those obtained for regular supraventricular arrhythmias
are expected in the future in the treatment of regular Ventricular and irre
gular supraventricular arrhythmias. Curr Opin Cardial 2000, 15:29-40 (C) 20
00 Lippincott Williams & Wilkins, Inc.